Relationship between apoptotic markers (Bax and bcl-2) and biochemical markers in type 2 diabetes mellitus

Singapore Medical Journal

Volumn 51, Issue 1, 2010, Pages 50-55

  Hasnan, J ^a   Yusof, M I ^b   Damitri, T D ^a   Faridah, A R ^b   Adenan, A S ^b   Norbaini, T H ^b  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^b Department of Orthopaedics ^*

Author keywords

Apoptosis; Biochemical markers; Type 2 diabetes mellitus

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN BAX; PROTEIN BCL 2; TRIACYLGLYCEROL;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN EXPRESSION; SKIN BIOPSY; TISSUE REGENERATION; TRIACYLGLYCEROL BLOOD LEVEL;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BIOLOGICAL MARKERS; BIOPSY; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; SKIN;

EID: 77950402132     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414:782-7.
2. Dasgupta MK. Strategies for managing diabetic patients on peritoneal dialysis. Adv Perit Dial 2004; 20:200-2.
3. Braunstein SN, White JR. Trends in the management of type 2 diabetes: an emerging role for insulin. J Manag Care Pharm 2005; 11:S2-S11.
4. Otero-Siliceo E, Ruano-Calderon LA. [Diabetic neuropathy: vascular disease?] Rev Neurol 2003; 37:658-61. Spanish.
5. Ruderman NB, Williamson JR, Brownlee M. Glucose and diabetic vascular disease. FASEB J 1992; 6:2905-14.
6. Mallat Z, Tedgui A. Apoptosis in the vasculature: mechanisms and functional importance. Br J Pharmacol 2000; 130:947-62.
7. Valeri C, Pozzilli P, Leslie D. Glucose control in diabetes. Diabetes Metab Res Rev 2004; 20 Suppl 2:S1-8.
8. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26:239-57.
9. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124:1-6.
10. Rosse T, Olivier R, Monney L, et al. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 1998; 391:496-9.
11. Galkowska H, Olszewsk WL, Wojewodzka U, Mijal J, Filipiuk E. Expression of apoptosis- and cell cycle-related proteins in epidermis of venous leg and diabetic foot ulcers. Surgery 2003; 134:213-20.
12. Podesta F, Romeo G, Liu WH, et al. Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am J Pathol 2000; 156:1025-32.
13. Abou-Seif MA, Youssef AA. Evaluation of some biochemical changes in diabetic patients. Clin Chim Acta 2004; 346:161-70.
14. Li ZG, Britton M, Sima AA, Dunbar JC. Diabetes enhances apoptosis induced by cerebral ischemia. Life Sci 2004; 76:249-62.
15. Tezel G, Wax MB. Inhibition of caspase activity in retinal cell apoptosis induced by various stimuli in vitro. Invest Ophthalmol Vis Sci 1999; 40:2660-7.
16. Isenmann S, Engel S, Gillardon F, Bahr M. Bax antisense oligonucleotides reduce axotomy-induced retinal ganglion cell death in vivo by reduction of Bax protein expression. Cell Death Differ 1999; 6:673-82.
17. Isenmann S, Wahl C, Krajewski S, Reed JC, Bähr M. Up-regulation of Bax protein in degenerating retinal ganglion cells precedes apoptotic cell death after optic nerve lesion in the rat. Eur J Neurosci 1997; 9:1763-72.
18. Chen ST, Hsu JR, Hsu PC, Chuang JI. The retina as a novel in vivo model for studying the role of molecules of the Bcl-2 family in relation to MPTP neurotoxicity. Neurochem Res 2003; 28:805-14.
19. Zhang C, Rosenbaum DM, Shaikh AR, et al. Ischemic preconditioning attenuates apoptotic cell death in the rat retina. Invest Ophthalmol Vis Sci 2002; 43:3059-66.
20. Ho FM, Liu SH, Liau C, Huang PJ, Lin-Shiau SY. High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3. Circulation 2000; 101:2618-24.
21. Du XL, Sui GZ, Stockklauser-Färber K, et al. Induction of apoptosis by high proinsulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species. Diabetologia 1998; 41:249-56.
22. Sekiguchi N, Inoguchi T, Kobayashi K, Nawata H. Effect of erythropoietin on endothelial cell apoptosis induced by high glucose. Diabetes Res Clin Pract 2004; 66 Suppl 1:S103-7.
23. Mizutani M, Gerhardinger C, Lorenzi M. Muller cell changes in human diabetic retinopathy. Diabetes 1998; 47:445-9.
24. Sgarbosa F, Barbisan LF, Brasil MA, et al. Changes in apoptosis and Bcl-2 expression in human hyperglycemic, term placental trophoblast. Diabetes Res Clin Pract 2006; 73:143-9.
25. Abu-El-Asrar AM, Dralands L, Missotten L, Al-Jadaan IA, Geboes K. Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci 2004; 45:2760-6.
26. Moley KH. Hyperglycemia and apoptosis: mechanisms for congenital malformations and pregnancy loss in diabetic women. Trends Endocrinol Metab 2001; 12:78-82.
27. Huppertz B, Frank HG, Kaufmann P. The apoptosis cascade - morphological and immunohistochemical methods for its visualization. Anat Embryol (Berl) 1999; 200:1-18.
28. Gao W, Ferguson G, Connell P, et al. High glucose concentrations alter hypoxia-induced control of vascular smooth muscle cell growth via a HIF-1 alpha-dependent pathway. J Mol Cell Cardiol 2007; 42:609-19.